{"id":"NCT03047980","sponsor":"Anne Comi, MD","briefTitle":"Trial of Sirolimus for Cognitive Impairment in Sturge-Weber Syndrome","officialTitle":"Trial of Sirolimus for Cognitive Impairment in Sturge-Weber Syndrome","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2017-01","primaryCompletion":"2019-06-04","completion":"2020-10-27","firstPosted":"2017-02-09","resultsPosted":"2021-11-01","lastUpdate":"2021-11-01"},"enrollment":10,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Sturge-Weber Syndrome"],"interventions":[{"type":"DRUG","name":"Sirolimus","otherNames":["Rapamycin","Rapamune"]}],"arms":[{"label":"Sirolimus","type":"EXPERIMENTAL"}],"summary":"The purpose of this research study is to gain a preliminary understanding of the safety of sirolimus in Sturge-Weber syndrome (SWS) and determine best outcomes to be used to assess the utility of sirolimus for the treatment of cognitive impairments related to Sturge-Weber syndrome.","primaryOutcome":{"measure":"Change in Cognitive Function as Assessed by the National Institute of Health (NIH) Toolbox Cognitive Battery","timeFrame":"Baseline and at 6 months on the study drug","effectByArm":[{"arm":"Sirolimus","deltaMin":44.2,"sd":12.5}],"pValues":[]},"eligibility":{"minAge":"3 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":2,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":["http://www.kennedykrieger.org/patient-care/patient-care-centers/sturge-weber-center"]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":10},"commonTop":["Hypertriglyceridemia","Skin Ulceration in Mouth","Increased aspartate aminotransferase","Decreased HDL Cholesterol","Headache"]}}